RTP Mobile Logo
Assessing Biomarker Analysis and the Use of EGFR- and ALK-Directed Therapy in Patients with Metastatic Nonsquamous Non­-Small Cell Lung Cancer (Video Program)
Released January 2018

Highlights of video interviews with lung cancer clinical oncology investigators Drs Geoffrey R Oxnard and Lecia V Sequist and pathologist Dr Lynette M Sholl on the current state of biomarker analysis and the related implications for treatment.

CE Disclosures and Faculty Information


    Geoffrey R Oxnard, MD
    Lowe Center for Thoracic Oncology
    Dana-Farber Cancer Institute
    Assistant Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts

    Lecia V Sequist, MD, MPH 
    Associate Professor of Medicine
    Harvard Medical School 
    Center for Thoracic Cancers
    Massachusetts General Hospital Cancer Center
    Boston, Massachusetts

    Lynette M Sholl, MD
    Associate Pathologist
    Brigham and Women’s Hospital, Department of Pathology
    Associate Director, Center for Advanced Molecular Diagnostics
    Assistant Professor
    Harvard Medical School
    Boston, Massachusetts

    This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

    This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Foundation Medicine and Genentech BioOncology.

    Hardware/Software Requirements:
    A high-speed Internet connection
    A monitor set to 1280 x 1024 pixels or more
    Internet Explorer 11 or later, Firefox 56 or later, Chrome 61 or later, Safari 11 or later, Opera 48 or later
    Adobe Flash Player 27 plug-in or later
    Adobe Acrobat Reader
    (Optional) Sound card and speakers for audio

    Release date: January 2018

Acknowledge and close

Watch videos
(WIFI is recommended for best performance):

Module 1: Mutation detection with next-generation sequencing

Module 2: EGFR mutation testing and treatment options

Module 3: Clinical considerations for disease progression on EGFR TKIs

Module 4: Testing for ALK rearrangements — Selecting the appropriate assay

Module 5: Role of checkpoint inhibitors in the treatment of non-small cell lung cancer (NSCLC)

Select Publications